Evidence Level
Oregano oil has shown significant antimicrobial activity in vitro and animal studies, though human clinical evidence remains limited. Force et al. (2000) conducted a small clinical trial demonstrating that an oregano oil emulsion resolved enteric parasites in most treated patients. Lu et al. (2018) confirmed carvacrol's broad-spectrum activity against bacteria, fungi, and viruses through membrane disruption, with MICs ranging from 0.08 to 0.64 mg/ml for multidrug-resistant pathogens like MRSA and Pseudomonas aeruginosa.
In animal studies, oregano oil has shown promise in improving growth performance and immune function. Mohiti-Asli and Ghanaatparast-Rashti (2015) found that dietary supplementation with 500 ppm oregano essential oil reduced coccidiosis severity in broiler chicks. However, Zaazaa et al. (2022) reported that while thyme or oregano oils improved growth performance in broilers, they also increased the prevalence of breast muscle abnormalities.
Despite its potential benefits, oregano oil's efficacy in human clinical settings remains understudied. Naturopathic practitioners commonly use it for acute infections and GI dysbiosis, but more rigorous human RCTs are needed to establish clinical protocols and optimize dosing regimens.